Regardless of its relationship to MITF, BRN2 expression oscillates between distinct stages of metastasis in vivo, and the gene itself can serve to either promote or suppress melanoma progression.26,38,39 Thus, the dynamic expression of BRN2, rather than its constant presence or absence, may be critical for melanoma progression. This evidence concerns the gene MITF and melanoma.